Immunohematology Market Set for Steady Growth as Blood Safety, Automation and Advanced Transfusion Diagnostics Gain Momentum

Immunohematology Market Overview

The Immunohematology Market is witnessing steady expansion as healthcare systems place greater emphasis on safe blood transfusion, accurate blood-group identification, antibody screening, and compatibility testing. According to Maximize Market Research, the market was valued at USD 2.58 billion in 2023 and is projected to reach USD 3.40 billion by 2030, growing at a CAGR of 4% during 2024–2030. 

Immunohematology plays a critical role in transfusion medicine by identifying blood groups and detecting antibodies that can cause adverse transfusion reactions. Increasing blood transfusion procedures, the growing prevalence of blood-related diseases, rising cancer incidence, and greater awareness of transfusion safety are supporting demand for immunohematology analyzers, reagents, and testing systems.

The market is also benefiting from laboratory automation and the transition from manual testing toward standardized, high-throughput workflows. Automated blood-grouping and antibody-testing systems can reduce manual intervention, improve turnaround times, and strengthen traceability. The increasing use of advanced diagnostic technologies and the expansion of blood banks and diagnostic laboratories in emerging economies are creating additional opportunities. At the same time, the high cost of analyzers and reagents and shortages of skilled professionals remain important market restraints. 

* Unlock Premium Market Intelligence:  

US Market Trends and Investment

The United States remains one of the most important markets for immunohematology because of its advanced healthcare infrastructure, extensive blood-bank network, sophisticated diagnostic laboratories, and established transfusion-safety practices. In 2025, companies continued investing in automation, digital connectivity, and blood-typing workflow optimization. Grifols highlighted centralized blood-typing middleware at its 2025 ISBT scientific symposium, focusing on improving safety, productivity, and laboratory workflow. Its Blood Typing Manager has also demonstrated the ability to connect immunohematology data and shorten turnaround times in hospital networks.  Bio-Rad continues to strengthen automated immunohematology testing through systems such as its IH-500, which provides continuous sample loading, onboard reagent stability, automated processing, and patient/QC data management. These developments reflect continued US demand for automated, connected, and efficient transfusion-testing infrastructure.

Market Segmentation

According to the MMR report, the market is segmented by Product, Application, End-user, and Region. By product, Immunohematology Reagents are expected to dominate the market during the forecast period. Increasing utilization of reagents in blood banks, customization of reagents for specific testing requirements, and the expanding use of immunohematology in diagnostic technologies are supporting the segment's leading position.

The report categorizes the product landscape into Immunohematology Analyzers and Immunohematology Reagents. Applications include Cancer Blood Typing, Antibody Screening, Blood-related Diseases, HIV, and Hepatitis, while end users comprise Hospitals, Academic and Research Institutes, Diagnostics and Reference Laboratories, and Blood Banks.

Immunohematology Market Key Players
1.Bio-Rad Laboratories, Inc.
2.Immucor
3.Grifols
4.BD (Becton Dickinson)
5.Hologic, Inc.
6.Siemens Healthcare GmbH
7.ThermoFisher
8.Abbott
9.Beckman Coulter, Inc.
10.Ortho Clinical Diagnostics
11.Roche Diagnostics Corporation
12.Merck KGaA
13.Cardinal Health Inc.
14.CSL Ltd.
15.Danaher Corp.
16.MTC Invitro Diagnostics AG
17.F. Hoffmann-La Roche Ltd.
18.Antisel

* Unlock Premium Market Intelligence:  

Competitive Analysis

The competitive landscape includes Bio-Rad Laboratories, Immucor, Grifols, BD (Becton Dickinson), Hologic, Siemens Healthcare, Thermo Fisher, Abbott, Beckman Coulter, Ortho Clinical Diagnostics, Roche Diagnostics, Merck KGaA, Cardinal Health, CSL, Danaher, MTC Invitro Diagnostics, F. Hoffmann-La Roche, and Antisel, according to the MMR report. The report does not provide individual percentage market shares for the five largest companies in the publicly available information; therefore, exact top-five share rankings are not stated here.

Bio-Rad Laboratories is strengthening laboratory automation through its IH-Complete portfolio, which combines instruments, reagents, connectivity, quality systems, cybersecurity, and technical support. Its IH-500 system uses a six-axis robotic arm and supports automated processing for small- and medium-sized laboratories. 

Grifols continues to expand automated immunohematology through its Erytra Eflexis platform, which automates blood grouping, Rh(D) typing, antigen typing, antibody detection and identification, titration, direct antiglobulin testing, and compatibility testing. 

Immucor, now part of Werfen, represents another important competitive force. Werfen's acquisition of Immucor strengthened its position in specialized diagnostic testing and transfusion medicine, expanding its immunohematology capabilities.

BD (Becton Dickinson) participates in the broader blood-management and diagnostic ecosystem, with opportunities arising from increasing demand for standardized transfusion workflows and laboratory efficiency.

Ortho Clinical Diagnostics, now operating as QuidelOrtho, remains an established participant in transfusion diagnostics. Historical industry filings identify Ortho, Beckman Coulter, Immucor, and Grifols as principal US immunohematology market participants. 

Regional Analysis

North America held the largest share of the Global Immunohematology Market in 2023, according to Maximize Market Research, and is projected to maintain its leading position during the forecast period. The region benefits from early adoption of advanced immunohematology techniques, a skilled workforce, established diagnostic centers and blood banks, and advanced healthcare infrastructure.

Within the region, the United States represents the principal growth market. Strong transfusion-safety requirements, sophisticated hospital systems, high healthcare expenditure, and investment in automated diagnostic technologies support demand. The country's mature blood-bank infrastructure also creates favorable conditions for replacing manual processes with connected and automated systems.

In Germany, France, and the UK, demand is supported by established healthcare systems and increasing laboratory automation. Japan benefits from advanced healthcare infrastructure and sophisticated diagnostic technology, while China offers long-term growth potential through healthcare infrastructure expansion and increasing adoption of modern laboratory technologies. The MMR report does not disclose individual country-level percentage shares for these countries, so specific country shares are not stated.

Conclusion

The Global Immunohematology Market is positioned for consistent expansion as healthcare providers prioritize blood safety, accurate compatibility testing, laboratory automation, and faster diagnostic workflows. The projected growth from USD 2.58 billion in 2023 to USD 3.40 billion by 2030 demonstrates the continuing importance of immunohematology within transfusion medicine.

In our view, the strongest growth opportunities will come from automated analyzers, advanced reagents, digital laboratory connectivity, antibody identification technologies, and integrated blood-bank information systems. Companies that can combine accuracy, automation, cybersecurity, workflow efficiency, and cost-effective testing are likely to gain an advantage. Expansion of blood-bank infrastructure in emerging markets and increasing demand for safer, standardized transfusion practices will further support the market's long-term development.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 [email protected]